연구성과로 돌아가기

2023 연구성과별 연구자 정보 (720 / 2675)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN Kolho, K. L. Kolho, KL 3 Childrens Hosp, Helsinki, Finland
Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN Kolho, K. L. Kolho, KL 3 Univ Helsinki, Helsinki, Finland
Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN Kolho, K. L. Kolho, KL 3 Tampere Univ, Dept Paediat Gastroenterol, Helsinki, Finland
Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN Aloi, M. Aloi, M 4 Sapienza Univ Rome, Dept Maternal & Child Health, Pediat Gastroenterol & Liver Unit, Umberto I Hosp, Rome, Italy
Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN Musto, F. Musto, F 5 Sapienza Univ Rome, Dept Maternal & Child Health, Pediat Gastroenterol & Liver Unit, Umberto I Hosp, Rome, Italy
Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN de-Carpi, J. M. de-Carpi, JM 6 Hosp St Joan Deu, Dept Pediat Gastroenterol Hepatol & Nutr, Barcelona, Spain
Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN Lozano-Ruf, A. Lozano-Ruf, A 7 Hosp St Joan Deu, Dept Pediat Gastroenterol Hepatol & Nutr, Barcelona, Spain
Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN Yogev, D. Yogev, D 8 Hebrew Univ Jerusalem, Juliet Keiden Inst Pediat Gastroenterol & Nutr, Shaare Zedek Med Ctr, Jerusalem, Israel
Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN Matar, M. Matar, M 9 Schneider Childrens Med Ctr, Tel Aviv, Israel
Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN Matar, M. Matar, M 9 Tel Aviv Univ, Inst Gastroenterol Nutr & Liver Dis, Sackler Fac Med, Tel Aviv, Israel
Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN Scarallo, L. Scarallo, L 10 Meyer Childrens Hosp, Gastroenterol & Nutr Unit, I-50139 Florence, Italy AAQ-9438-2020 Scarallo, Luca
Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN Bramuzzo, M. Bramuzzo, M 11 IRCCS Burlo Garofolo, Gastroenterol Digest Endoscopy & Nutr Unit, Inst Maternal & Child Hlth, Trieste, Italy
Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN de Ridder, L. de Ridder, L 12 Erasmus MC, Sophia Childrens Hosp, Dept Paediat Gastroenterol, Rotterdam, Netherlands
Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN Kang, B. Kang, B 13 Kyungpook Natl Univ, Sch Med, 130 Dongdeok Ro, Daegu 41944, South Korea
Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN Norden, C. Norden, C 14 Copenhagen Univ Hosp, Paediat Dept, Hvidovre, Denmark
페이지 이동: